1-26794501-G-A

Variant names:

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong

The NM_017837.4(PIGV):c.467G>A(p.Cys156Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.000125 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C156S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)

Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

PIGV
NM_017837.4 missense

Scores

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 6.16

Publications

13 publications found

Variant links:

Genes affected

PIGV (HGNC:26031): (phosphatidylinositol glycan anchor biosynthesis class V) This gene encodes a mannosyltransferase enzyme involved in the biosynthesis of glycosylphosphatidylinositol (GPI). GPI is a complex glycolipid that functions as a membrane anchor for many proteins and plays a role in multiple cellular processes including protein sorting and signal transduction. The encoded protein is localized to the endoplasmic reticulum and transfers the second mannose to the GPI backbone. Mutations in this gene are associated with hyperphosphatasia cognitive disability syndrome. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Feb 2011]

PIGV Gene-Disease associations (from GenCC):

hyperphosphatasia with intellectual disability syndrome 1
Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
hyperphosphatasia-intellectual disability syndrome
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

PIGV links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PP3

MetaRNN computational evidence supports a deleterious effect, 0.965

PP5

Variant 1-26794501-G-A is Pathogenic according to our data. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-26794501-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 30821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PIGV	NM_017837.4 link	c.467G>A	p.Cys156Tyr	missense_variant	Exon 3 of 4	ENST00000674202.1	NP_060307.2	Q9NUD9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PIGV	ENST00000674202.1 link	c.467G>A	p.Cys156Tyr	missense_variant	Exon 3 of 4		NM_017837.4	ENSP00000501479.1		Q9NUD9

Frequencies

GnomAD3 genomes

AF:

0.0000526

AC:

AN:

152192

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.0000654

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.000103

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.000103

AC:

AN:

251482

AF XY:

0.0000956

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.0000462

Gnomad NFE exome

AF:

0.000220

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.000132

AC:

193

AN:

1461892

Hom.:

Cov.:

AF XY:

0.000136

AC XY:

AN XY:

727248

show subpopulations

African (AFR)

AF:

0.0000299

AC:

AN:

33480

American (AMR)

AF:

0.00

AC:

AN:

44724

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86258

European-Finnish (FIN)

AF:

0.0000374

AC:

AN:

53420

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.000169

AC:

188

AN:

1112010

Other (OTH)

AF:

0.0000331

AC:

AN:

60396

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.476

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000526

AC:

AN:

152192

Hom.:

Cov.:

AF XY:

0.0000673

AC XY:

AN XY:

74338

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41452

American (AMR)

AF:

0.0000654

AC:

AN:

15282

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5198

South Asian (SAS)

AF:

0.00

AC:

AN:

4830

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10610

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.000103

AC:

AN:

68034

Other (OTH)

AF:

0.00

AC:

AN:

2090

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.506

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000116

Hom.:

Bravo

AF:

0.0000642

TwinsUK

AF:

0.000270

AC:

ALSPAC

AF:

0.00

AC:

ExAC

AF:

0.000123

AC:

EpiCase

AF:

0.0000545

EpiControl

AF:

0.000237

ClinVar

Significance: Pathogenic/Likely pathogenic

Submissions summary: Pathogenic:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Pathogenic:3

Jul 13, 2023

Clinical Genetics Laboratory, Skane University Hospital Lund

Significance:Likely pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jun 18, 2025

GeneDx

Significance:Likely pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Observed with a missense variant in patients with features consistent with PIGV-related GPI biosynthesis disorder in the published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (PMID: 35080266, 22315194); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27177984, 23561846, 31589614, 22315194, 35080266, 33528536, 38414627, 21739589, 34441372) -

Dec 17, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 156 of the PIGV protein (p.Cys156Tyr). This variant is present in population databases (rs387907023, gnomAD 0.02%). This missense change has been observed in individual(s) with hyperphosphatasia with intellectual disability (PMID: 21739589, 22315194). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 30821). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PIGV protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -

Hyperphosphatasia with intellectual disability syndrome 1

Pathogenic:1

Aug 01, 2011

OMIM

Significance:Pathogenic

Review Status:no assertion criteria provided

Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Pathogenic

0.82

BayesDel_addAF

Pathogenic

0.24

BayesDel_noAF

Pathogenic

0.39

CADD

Pathogenic

(source)

DANN

Uncertain

1.0

DEOGEN2

Pathogenic

0.81

D;D;.

Eigen

Pathogenic

0.79

Eigen_PC

Pathogenic

0.74

FATHMM_MKL

Pathogenic

0.98

LIST_S2

Uncertain

0.91

.;D;D

M_CAP

Uncertain

0.21

MetaRNN

Pathogenic

0.96

D;D;D

MetaSVM

Uncertain

0.75

MutationAssessor

Pathogenic

3.7

H;H;.

PhyloP100

6.2

PrimateAI

Uncertain

0.79

PROVEAN

Pathogenic

-8.7

D;D;D

REVEL

Pathogenic

0.86

Sift

Uncertain

0.0020

D;D;D

Sift4G

Uncertain

0.0040

D;D;D

Polyphen

1.0

D;D;.

Vest4

0.87

MVP

0.97

MPC

0.81

ClinPred

0.99

GERP RS

4.6

Varity_R

0.87

gMVP

0.68

Mutation Taster

=7/93

disease causing (ClinVar)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over